Bioassay Systems Corp said its
common stock was deleted from Nasdaq as of March 17 because two
of the company's three market makers ceased trading in the
stock.
    The company also said it agreed to sell for 100,000 dlrs
assets of its closed Woburn, Mass., plant to &lt;Toxikon Corp>, 
which will assume the lease on the facility.
    Bioassay's common stock will continue to be traded in the
National Daily Quotation, or pink, sheets, it said.
 Reuter
&#3;